Social risk as a risk factor for medication non-adherence in patients over 65 years old with type 2 diabetes mellitus
Article Sidebar
Main Article Content
Abstract
Aims: The aim of this study was to establish the influence of social risk and its
relation on therapeutic adherence to pharmacological treatment of diabetes mellitus type 2 (DM2) in people older than 65 years. Method: A cross-sectional descriptive study based on the electronic clinical records of primary care in people over 65 years of age with DM2 of north area of Madrid (n = 26703). Multivariate logistic regression analysis was performed for Non-Adherence to Treatment (Non-AdhT) and for poor control of DM2, disaggregated by sex. Results: A 33,7% had poor control of DM2 and 3.1% Non-AdhT. In regression models for poor DM2 control, the Non-AdhT increased (OR: 1.64; 95% CI: 1.07-2.51). In both sexes, social risk causes a greater lack of adherence, in women (5.7% vs. 1.9%, p = 0.000), men (7.5% vs. 2.3%, p = 0.000). In the regression models for non-AdhT, it was increased to have a social risk (OR: 2.92, 95% CI: 1.61-5.30) in women; social risk (OR = 3.52, 95% CI 1.90-6.52) was associated with non-adherence also in men. Discussion: In those older than 65 years with DM2, although the No AdhT is low, the prevalence of poor control is high. For Non-AdhT, social risk is a risk factor for both sexes, but having depression increases Non-AdhT in women, and anxiety symptoms in men. No AdhT raises the risk of poor control of DM2, especially in women; as well as not dieting and being overweight/obese.
Downloads
Article Details
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
References
Aflakseir, A., & Malekpour, F. (2014). The Role of Self-Efficacy and Social Support in Predicting Depression Symptoms in Diabetic Patients. Iranian Journal of Diabetes and Obesity, 6(3).
Axon, R. N. (2016). Comorbid depression is differentially depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetes. Medicine, 30(95), 1–7.
Ayçaguer, S. (1997). Cultura estadística e investigación científica en el campo de la salud: una mirada crítica. Madrid: Diaz Santos.
Basterra-Gortari FJ, B.-R. M. et al. (2017). Prevalencia de obesidad y diabetes en adultos españoles, 1987-2012.
Medicina Clínica, 148(6), 250–256. https://doi.org/10.1016/j.medcli.2016.11.022
Beléndez, M. (2015). Estrés emocional y calidad de vida en personas con diabetes y sus familiares. Gaceta Sanitaria, 29(4), 300–303.
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., Rocha, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF Diabetes Atlas : Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271–281. https://doi.org/10.1016/j.diabres.2018.02.023
Cimbage, C., Thomasz, O., Caruana, C., Eugenia, M., Miguel, J., Thomasz, E. O., … Miguel, J. (2014). Riesgo social: medición de la vulnerabilidad en grupos focalizados. Cuadernos del CIMBAGE, 16, 27–51.
Débora Álvarez-delArco, MartaVicente Sánchez, BelénAlejos, C. P. y E. R. (2013). Construcción de un índice de privación para los barrios de Madrid y Barcelona. Revista Española de Salud Pública, 87, 317–329.
DL, C. (2010). Moving to an A1C-Based Diagnosis of Diabetes Has a Different Impact on Prevalence in Different Ethnic Groups. Diabetes Care, 33(3), 580–582.
Dominguez-Berjón MF, Borrel C, Cano-Serral G, Esnaola S, Nolasco A, P. M. (2008). Construcción de un índice de privación a partir de datos censales en grandes ciudades españolas (Proyecto MEDEA). Gaceta Sanitaria,
(3), 179–187.
Espelt, A., Borrell, C., Palència, L., Goday, A., Spadea, T., Gnavi, R., … Kunst, A. E. (2013). Socioeconomic inequalities in the incidence and prevalence of type 2 diabetes mellitus in Europe. Gaceta Sanitaria, 27(6), 494–501. https://doi.org/10.1016/j.gaceta.2013.03.002
Funnell, M. (2006). The Diabetes Attitudes, Wishes and Needs (DAWN) study. Clinical Diabetes, 4(24), 154–155.
Gandarillas Ana María, Valero Virginia, G. M. (2018). Estudio PREDIMERC 2015 PREvalencia de DIaberes MEllitus y Riesgo Cardiovascular en población adulta de la Comunidad de Madris. Madrid.
Garcia, M. L., Castañeda, S. F., Allison, M. A., Elder, J. P., & Talavera, G. A. (2019). Correlates of Low-adherence to Oral Hypoglycemic Medications among Hispanic/Latinos of Mexican Heritage with Type 2 Diabetes in the United States. Diabetes Research and Clinical Practice, 18(31), 644–649.
https://doi.org/10.1016/j.diabres.2019.04.007
Harandi, T. F., Taghinasab, M. M., & Nayeri, T. D. (2017). The correlation of social support with mental health: A meta-analysis. Electronic Physician, (September), 5212–5222.
Joseph, J. J., & Golden, S. H. (2018). Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Annals of the New York Academy of Sciences, 1391(1), 20–34. https://doi.org/10.1111/nyas.13217.Cortisol
Joshep JJ, G. S. (2017). Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Annals of the New York Academy of Sciences, 1(1391), 20–34.
Koetsenruijter, J., Eikelenboom, N. Van, Lieshout, J. Van, Vassilev, I., Lionis, C., Todorova, E., … Wensing, M.
(2016). Social support and self-management capabilities in diabetes patients : An international observational study. Patient Education and Counseling, 99(4), 638–643. https://doi.org/10.1016/j.pec.2015.10.029
Maheri, A., Sadeghi, R., Shojaeizadeh, D., Tol, A., Yaseri, M., & Rohban, A. (2018). Depression , Anxiety , and Perceived Social Support among Adults with Beta- Thalassemia Major : Cross-Sectional Study, 101–107.
OMS. (2018). Obesidad y Sobrepeso. Recuperado el 15 de diciembre de 2018, a partir de https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight
Osborn, C. Y., Ph, D., H, M. P., Egede, L. E., & S, M. (2012). The relationship between depressive symptoms and medication nonadherence in type 2 diabetes : the role of social support , . General Hospital Psychiatry, 34(3), 249–253. https://doi.org/10.1016/j.genhosppsych.2012.01.015
Parro Moreno A, Santiago Pérez IM, Abraira V, Aréjula Torres JL, Gandarillas-Grande A, Díaz Holgado A, Morales Asencio JM, S. P. (2016). Control de la diabetes mellitus en población adulta según las características del personal de enfermería de atención primaria de la comunidad de Madrid: Análisis multinivel. Revista Española de Salud Pública, 90(4).
Primaria, D. G. de A. (2016). Informe Estado de Salud de la Población de la Comunidad de Madrid: objetivo 5 Envejecer en buena salud. Recuperado el 30 de noviembre de 2018, a partir de http://www.comunidad.madrid/sites/default/files/doc/sanidad/epid/ies2016_objetivo5.pdf
Ramkisson, S. (2017). Social support and coping in adults with type 2 diabetes. African Journal of Primary Health Care and Family Medicine, 9(1), 1–8.
Risk, N. C. D., & Collaboration, F. (2016). Worldwide trends in diabetes since 1980 : a pooled analysis of 751 population-based studies with 4 · 4 million participants. The Lancet, 387(10027), 1513–1530. https://doi.org/10.1016/S0140-6736(16)00618-8
Rotella F, M. E. (2013). Diabetes mellitus as a risk factor for depression. Diabetes research and clinical practice, 2(98), 98–104.
Smalls, B. L., A, M. H. S., Walker, R. J., S, M., Hernandez-tejada, M. A., S, M., … S, M. (2012). Associations between coping , diabetes knowledge , medication adherence and self-care behaviors in adults with type 2 diabetes . General Hospital Psychiatry, 34(4), 385–389. https://doi.org/10.1016/j.genhosppsych.2012.03.018
Soler-González,J., Marsal,J. R., Serna, C., Real,J., Cruz, I., & López, A. (2013). La población inmigrante controla peor su diabetes que la población autóctona. Gaceta Sanitaria, 27(1), 19–25. https://doi.org/10.1016/j.gaceta.2011.12.015
Tovar, E., Rayens, M. K., Gokun, Y., & Clark, M. (2013). Mediators of adherence among adults with comorbid diabetes and depression : The role of self-efficacy and social support. Journal of Health Psychology, 20(11), 1405–1415. https://doi.org/10.1177/1359105313512514
Val Jiménez A, Amorós Ballestero G, Martínez Visa P, Fernández Ferré ML, L. S. M. (1992). Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test. Atención Primariarimaria, 10(5), 767–770.
WHO. (2016). World Health Organization. Global status report on noncommunicable disease, Diabetes. Recuperado a partir de https://www.who.int/diabetes/country-profiles/mex_es.pdf?ua=1
WHO. (2018). World Health Organization. Global Report on Diabetes. Recuperado a partir de https://www.who.int/diabetes/global-report/en/
Williams, A., Sethi, B., Duggleby, W., Ploeg, J., Markle-reid, M., & Peacock, S. (2016). A Canadian qualitative study exploring the diversity of the experience of family caregivers of older adults with multiple chronic conditions using a social location perspective. International Journal for Equity in Health, 1–16.
https://doi.org/10.1186/s12939-016-0328-6
Wonca. (1999). Clasificación Internacional de Atención Primaria CIAP-2 (depresión y ansiedad). Recuperado el 20 de agosto de 2006, a partir de https://www.iqb.es/patologia/ciap/ciap_p.htm
WONCA. (1999). Clasificación Internacional de Atención Primaria CIAP-2 Diabetes. Recuperado el 28 de noviembre de 2018, a partir de https://www.iqb.es/patologia/ciap/ciap_